Keros Therapeutics
KROS
$57.49
Share price
-0.40%
Change (1 day)
24.79%
Change (1 year)
Categories
Keros Therapeutics (KROS) - Total assets
Total assets on the balance sheet as of December 2023 : $0.37 B
According to Keros Therapeutics's latest financial reports the company's total assets are $0.37 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Keros Therapeutics - Total assets on balance sheet (from 2019 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.37 B | 20.62% |
| 2022-12-31 | $0.30 B | 20.19% |
| 2021-12-31 | $0.25 B | -5.27% |
| 2020-12-31 | $0.26 B | 2359.54% |
| 2019-12-31 | $10.95 M | -60.04% |
| 2018-12-31 | $27.41 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | -31.89% | 🇺🇸 USA |